AU2002327182B2 - Novel heterocyclic antibacterial compounds - Google Patents

Novel heterocyclic antibacterial compounds Download PDF

Info

Publication number
AU2002327182B2
AU2002327182B2 AU2002327182A AU2002327182A AU2002327182B2 AU 2002327182 B2 AU2002327182 B2 AU 2002327182B2 AU 2002327182 A AU2002327182 A AU 2002327182A AU 2002327182 A AU2002327182 A AU 2002327182A AU 2002327182 B2 AU2002327182 B2 AU 2002327182B2
Authority
AU
Australia
Prior art keywords
ethyl
oxo
carboxy
methylanilino
quinolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002327182A
Other languages
English (en)
Other versions
AU2002327182A1 (en
Inventor
George E. Wright
Chengxin Zhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbiotix Inc
Original Assignee
Microbiotix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbiotix Inc filed Critical Microbiotix Inc
Publication of AU2002327182A1 publication Critical patent/AU2002327182A1/en
Application granted granted Critical
Publication of AU2002327182B2 publication Critical patent/AU2002327182B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2002327182A 2001-06-15 2002-06-17 Novel heterocyclic antibacterial compounds Ceased AU2002327182B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US29853901P 2001-06-15 2001-06-15
US60/298,539 2001-06-15
US34884002P 2002-01-14 2002-01-14
US60/348,840 2002-01-14
US34981502P 2002-01-17 2002-01-17
US60/349,815 2002-01-17
PCT/US2002/019148 WO2002102792A1 (en) 2001-06-15 2002-06-17 Novel heterocyclic antibacterial compounds

Publications (2)

Publication Number Publication Date
AU2002327182A1 AU2002327182A1 (en) 2003-05-15
AU2002327182B2 true AU2002327182B2 (en) 2005-09-15

Family

ID=27404574

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002327182A Ceased AU2002327182B2 (en) 2001-06-15 2002-06-17 Novel heterocyclic antibacterial compounds

Country Status (6)

Country Link
EP (1) EP1401829B1 (enExample)
JP (1) JP4462926B2 (enExample)
AU (1) AU2002327182B2 (enExample)
CA (1) CA2450122C (enExample)
ES (1) ES2392819T3 (enExample)
WO (1) WO2002102792A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1472254A4 (en) * 2002-02-08 2006-02-15 Glsynthesis Inc PURINE AND ISOSTERIC ANTIBACTERIAL COMPOUNDS
US7884099B2 (en) 2007-11-16 2011-02-08 Cumbre Ip Ventures, L.P. Quinolone carboxylic acid-substituted rifamycin derivatives
WO2011031935A1 (en) * 2009-09-11 2011-03-17 Glsynthesis Inc. Selective antibacterials for clostridium difficile infections
AR096135A1 (es) 2013-05-02 2015-12-09 Actelion Pharmaceuticals Ltd Derivados de la quinolona

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
CA2199645C (en) * 1997-03-11 1999-06-29 Apotex Inc. Methods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereof

Also Published As

Publication number Publication date
EP1401829B1 (en) 2012-08-22
JP4462926B2 (ja) 2010-05-12
CA2450122C (en) 2009-10-20
ES2392819T3 (es) 2012-12-14
EP1401829A4 (en) 2004-10-27
JP2004535427A (ja) 2004-11-25
CA2450122A1 (en) 2002-12-27
EP1401829A1 (en) 2004-03-31
WO2002102792A1 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
US6777420B2 (en) Heterocyclic antibacterial compounds
JP7286317B2 (ja) Ａｃｉｎｅｔｏｂａｃｔｅｒ ｂａｕｍａｎｎｉｉに対するペプチド大環状分子
ES2298260T3 (es) Derivados de piridina con actividad inhibidora de quinasa ikb (ikk-beta).
JP5167291B2 (ja) ジヒドロピラゾロピリミジノン誘導体
AU2010206744B2 (en) Poly (ADP-ribose) polymerase (PARP) inhibitors
KR100944645B1 (ko) 자이라제 억제제 및 이를 포함하는 약제학적 조성물
MX2007011850A (es) Inhibidores heterobiciclicos de virus de hepatitis c.
EP2913330A1 (en) Condensed derivatives of imidazole useful as pharmaceuticals
SA04250088A (ar) مركبات كيميائية
JP2012528137A (ja) 複素環式尿素誘導体およびそれらの使用方法
US20250049814A1 (en) 5-azaindazole derivatives as adenosine receptor antagonists
JP2004505953A (ja) ヘテロ環ムチリンエステル及び抗細菌剤としてのその使用
KR102435777B1 (ko) 카르바페넴 화합물
KR20160115986A (ko) 폴리믹신을 포함하는 항균성 조합
AU2002327182B2 (en) Novel heterocyclic antibacterial compounds
EP3774790B1 (en) Oxazolidinone antibiotic compounds and process of preparation
AU2002327182A1 (en) Novel heterocyclic antibacterial compounds
JPH02290870A (ja) 対掌体的に純粋な７‐（３‐アミノ‐１‐ピロリジニル）‐キノロン‐および‐ナフチリドンカルボン酸
EP3717490B1 (en) Anti-bacterial heterocyclic compounds and their synthesis
US20230365531A1 (en) Inhibitors of human respiratory syncytial virus and metapneumo virus
CN116669769A (zh) Helios的哌啶基小分子降解剂和使用方法
WO2015071780A1 (en) Alkylidine substituted heterocyclyl derivatives as anti-bacterial agents

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired